Sun's Derisked Gleevec Generic Set For 2016 Launch
This article was originally published in Scrip
Executive Summary
Shares of Sun Pharmaceutical Industries Ltd spurted on Indian bourses after the firm's subsidiary received final FDA approval for its ANDA for imatinib mesylate tablets 100mg and 400mg, generic versions of Novartis' chronic myeloid leukemia therapy, Gleevec.